Wird geladen...
Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy
BACKGROUND: Cerebral palsy (CP) is the most common cause of physical disabilities in children in high‐income countries. Spasticity is the most common motor disturbance in CP. Botulinum toxin type A (BoNT‐A) is considered the first‐line treatment for focal spasticity in people with CP. OBJECTIVES: To...
Gespeichert in:
| Veröffentlicht in: | Cochrane Database Syst Rev |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley & Sons, Ltd
2019
|
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6779591/ https://ncbi.nlm.nih.gov/pubmed/31591703 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001408.pub2 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|